Astragalosides isolated from the root of astragalus radix inhibit the formation of advanced glycation end products

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 17, 2009, Pages 7666-7672

  Motomura, Keita ^a   Fujiwara, Yukio ^a   Kiyota, Naoko ^a   Tsurushima, Keiichiro ^a   Takeya, Motohiro ^a   Nohara, Toshihiro ^c   Nagai, Ryoji ^b   Ikeda, Tsuyoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAPAN WOMEN'S UNIVERSITY   (Japan)

^c SOJO UNIVERSITY   (Japan)

Author keywords

Advanced glycatlon end products; Astragali radix; Astragaloside; N (carboxymethyl)lysine; Pentosidine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ARGININE; ASTRAGALOSIDE A; DRUG DERIVATIVE; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE; PENTOSIDINE; PLANT EXTRACT; SAPONIN; TRITERPENE;

ARTICLE; ASTRAGALUS PLANT; CHEMISTRY; DIABETES MELLITUS; DRUG ANTAGONISM; ISOLATION AND PURIFICATION; PLANT ROOT;

ARGININE; ASTRAGALUS PLANT; DIABETES COMPLICATIONS; GLYCOSYLATION END PRODUCTS, ADVANCED; LYSINE; PLANT EXTRACTS; PLANT ROOTS; SAPONINS; TRITERPENES;

ASTRAGALUS MEMBRANACEUS; BOVINAE; RATTUS;

EID: 69949184453     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf9007168     Document Type: Article

References (33)

1. Sell, D. R.; Monnier, V. M. End-stage renal disease and diabetes catalyze the formation of a pentose-derived crosslink from aging human collagen. J. Clin. Invest. 1990, 55 (2), 380-384.
2. Araki, N.; Ueno, N.; Chakrabarti, B.; Morino, Y.; Horiuchi, S. Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J. Biol. Chem. 1992, 257(15), 10211-10214.
3. (3) Vlassara, H.; Bucala, R.; Striker, L. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest. 1994, 70 (2), 138-151. (Pubitemid 24090096)
4. Sell, D. R.; Monnier, V. M. Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J. Biol. Chem. 1989, 264 (36), 21597-21602.
5. Baynes, J. W. Role of oxidative stress in development of complications in diabetes. Diabetes 1991, 40 (4), 405-412.
6. Monnier, V. M.; Sell, D. R.; Nagaraj, R. H.; Miyata, S.; Grandhee, S.; Odetti, P.; Ibrahim, S. A., Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia. Diabetes 1992, 41 (Suppl. 2), 36-41.
7. Odetti, P.; Fogarty, J.; Sell, D. R.; Monnier, V. M. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 1992, 41 (2), 153-159.
8. Sell, D. R.; Lapolla, A.; Odetti, P.; Fogarty, J.; Monnier, V. M. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 1992, 41 (10), 1286-1292.
9. Taneda, S.; Monnier, V. M. ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin. Chem. 1994, 40 (9), 1766-1773.
10. Miyata, T.; Taneda, S.; Kawai, R.; Ueda, Y.; Horiuchi, S.; Hara, M.; Maeda, K.; Monnier, V. M. Identification of pentosidine as a native structure for advanced glycation end products in β-2-microglobulincontaining amyloid fibrils in patients with dialysis-related amyloidosis. Proc. Natl. Acad. Sci. U.S.A. 1996, 93 (6), 2353-2358.
11. (11) Hricik, D. E.; Schulak, J. A.; Sell, D. R.; Fogarty, J. F.; Monnier, V. M. Effects of kidney or kidney-pancreas transplantation on plasma pentosidine. Kidney Int. 1993, 43 (2), 398-403. (Pubitemid 23162833)
12. ε-(carboxymethyl)lysine formation from Amadori product. Biochem. Biophys. Res. Commun. 1997, 234 (1), 167-172.
13. ε- (carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes 2002, 51 (9), 2833-2839.
14. ε-(carboxymethyl)lysine from Amadori products. Free Radical Res. 2007, 41 (6), 713-718.
15. Booth, A. A.; Khalifah, R. G.; Todd, P.; Hudson, B. G. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways. J. Biol. Chem. 1997, 272 (9), 5430-5437.
16. (16) Nakamura, Y.; Kawakami, M.; Yoshihiro, A.; Miyoshi, N.; Ohigashi, H.; Kawai, K.; Osawa, T.; Uchida, K. Involvement of the mitochondrial death pathway in chemopreventive benzyl isothiocyanate-induced apoptosis. J. Biol. Chem. 2002, 277(10), 8492-8499. (Pubitemid 34968311)
17. Degenhardt, T. P.; Alderson, N. L.; Arrington, D. D.; Beattie, R. J.; Basgen, J. M.; Steffes, M. W.; Thorpe, S. R.; Baynes, J. W. Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat. Kidney Int. 2002, 61 (3), 939-950.
18. Stitt, A.; Gardiner, T. A.; Alderson, N. L.; Canning, P.; Frizzell, N.; Duffy, N.; Boyle, C.; Januszewski, A. S.; Chachich, M.; Baynes, J. W.; Thorpe, S. R. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 2002, 51 (9), 2826-2832.
19. (19) Yamabe, N.; Kang, K. S.; Goto, E.; Tanaka, T.; Yokozawa, T. Beneficial effect of Comi Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats. Biol. Pharm. Bull. 2007, 30 (3), 520-526. (Pubitemid 46355938)
20. (20) Miyazaki, K.; Nagai, R.; Horiuchi, S. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product. J. Biochem. 2002, 132 (4), 543-550. (Pubitemid 35238907)
21. Grandhee, S. K.; Monnier, V. M. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J. Biol. Chem. 1991, 266 (18), 11649-11653.
22. Kitagawa, I.; Wang, H.; Takagi, A.; Fukuda, M.; Miura, I.; Yoshikawa, M. Saponin and sapogenol. XXXV. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge. (2). Astragalosides I, II and IV, acetylastragaloside I and isoastragalosides I and II. Chem. Pharm. Bull. 1983, 31 (2), 698-708.
23. Kitagawa, I.; Wang, H.; Saito, M.; Yoshikawa, M. Saponin and sapogenol. XXXVI. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge. (3). Astragalosides III, V, and VI. Chem. Pharm. Bull. 1983, 31 (2), 709-715.
24. Kitagawa, I.; Wang, H.; Yoshikawa, M. Saponin and sapogenol. XXXVII. Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge. (4). Astragalosides VII and VIII. Chem. Pharm. Bull. 1983, 31 (2), 716-722.
25. (25) Nagai, R.; Hayashi, C. M.; Xia, L.; Takeya, M.; Horiuchi, S. Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins. J. Biol. Chem. 2002, 277 (50), 48905-48912. (Pubitemid 35470860)
26. ε-(carboxyethyl)lysine, one of the methylglyoxalderived AGE structures, in glucose-modified protein: mechanism for protein modification by reactive aldehydes. J. Chromatogr.,B: Anal. Technol. Biomed. Life Sci. 2003, 788 (1), 75-84.
27. Akagawa, M.; Shigemitsu, T.; Suyama, K. Production of hydrogen peroxide by polyphenols and polyphenol-rich beverages under quasiphysiological conditions. Biosci., Biotechnol., Biochem. 2003, 57(12), 2632-2640.
28. Shao, B. M.; Xu, W.; Dai, H.; Tu, P.; Li, Z.; Gao, X. M. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem. Biophys. Res. Commun. 2004, 320 (4), 1103-1111.
29. Ma, X. Q.; Shi, Q.; Duan, J. A.; Dong, T. T.; Tsim, K. W. Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. J. Agrie. Food Chem. 2002, 50, 4861-4866.
30. (30) Kusum, M.; Klinbuayaem, V.; Bunjob, M.; Sangkitporn, S. Preliminary efficacy and safety of oral suspension SH, combination of five Chinese medicinal herbs, in people living with HIV/AIDS ; the phase I/II study. J. Med. Assoc. Thai 2004, 57(9), 1065-1070. (Pubitemid 39361410)
31. Wang, R. T.; Shan, B. E.; Li, Q. X. [Extracorporeal experimental study on immuno-modulatory activity of Astragalus memhranaceus extract]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2002, 22 (6), 453-456.
32. (32) Zhang, Y. W.; Xie, D.; Chen, Y. X.; Zhang, H. Y.; Xia, Z. X. Protective effect of Gui Qi mixture on the progression of diabetic nephropathy in rats. Exp. Clin. Endocrinol. Diabetes 2006, 114 (10), 563-568. (Pubitemid 46087262)
33. (33) Li, S.; Zhang, Y.; Zhao, J. Preparation and suppressive effect of astragalus polysaccharide in glomerulonephritis rats. Int. ImmunoPharmacol. 2007, 7(1), 23-28. (Pubitemid 44856388)